期刊
ACTA BIOMATERIALIA
卷 9, 期 3, 页码 5447-5452出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2012.11.006
关键词
Lipid-polymer hybrid nanoparticles; Magnetic beads; Drug delivery; Controlled drug release
资金
- Iwama Fund at the University of California San Diego
- NSF [DMR-1006081, CMMI-1031239]
- Directorate For Engineering
- Div Of Civil, Mechanical, & Manufact Inn [1031239] Funding Source: National Science Foundation
Stimuli-responsive nanoparticles (SRNPs) offer the potential of enhancing the therapeutic efficacy and minimizing the side-effects of chemotherapeutics by controllably releasing the encapsulated drug at the target site. Currently controlled drug release through external activation remains a major challenge during the delivery of therapeutic agents. Here we report a lipid-polymer hybrid nanoparticle system containing magnetic beads for stimuli-responsive drug release using a remote radio frequency (RF) magnetic field. These hybrid nanoparticles show long-term stability in terms of particle size and polydispersity index in phosphate-buffered saline (PBS). Controllable loading of camptothecin (CPT) and Fe3O4 in the hybrid nanoparticles was demonstrated. RF-controlled drug release from these nanoparticles was observed. In addition, cellular uptake of the SRNPs into MT2 mouse breast cancer cells was examined. Using CPT as a model anticancer drug the nanoparticles showed a significant reduction in MT2 mouse breast cancer cell growth in vitro in the presence of a remote RF field. The ease of preparation, stability, and controllable drug release are the strengths of the platform and provide the opportunity to improve cancer chemotherapy. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据